Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot study

1 Nov 2021

Abstract excerpt

Introduction MicroRNAs (miRs) may be important regulators of risk for type 2 diabetes (T2D). Circulating miRs may provide information about which individuals are at risk for T2D. The purpose of this study was to assess longitudinal associations between circulating miR expression and variability in fasting blood glucose (FBG) and to identify miR-targeted genes and biological pathways. Methods Variability in FBG...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Effects on Health
Share to Hydrogen's biological and therapeutic effects
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34846185
DOI: 10.1177/14791641211055837

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating microRNAs are associated with variability in fasting blood glucose over 12-months and target pathways related to type 2 diabetes: A pilot studyPMID 34846185Read ↗

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 DiabetesSemantic proximity Read ↗

Preliminary evidence supports circulating microRNAs as prognostic biomarkers for type 2 diabetesSemantic proximity Read ↗

Circulating miRNA expression in long-standing type 1 diabetes mellitusSemantic proximity Read ↗

Circulating miR-103 family as potential biomarkers for type 2 diabetes through targeting CAV-1 and SFRP4Semantic proximity Read ↗

MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related ComplicationsSemantic proximity Read ↗

Circulating Nucleic Acid-Based Biomarkers of Type 2 DiabetesSemantic proximity Read ↗

A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV studySemantic proximity Read ↗

MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes StatesSemantic proximity Read ↗

Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetes.Semantic proximity Read ↗

Longitudinal Associations Between MicroRNAs and Weight in the Diabetes Prevention ProgramSemantic proximity Read ↗

Continuous glucose monitor–derived glucotypes and cardiovascular risk scores in individuals without diabetesSemantic proximity Read ↗

Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic HomeostasisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.